| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | -0.21 | 1e-09 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.22 | 2e-09 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | -0.2 | 2e-08 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | -0.2 | 3e-08 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | 0.19 | 2e-07 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | -0.2 | 2e-07 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | 0.19 | 9e-07 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | -0.15 | 2e-06 |
| mRNA | TG-101348 | GDSC1000 | pan-cancer | AAC | -0.15 | 3e-06 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.3 | 3e-06 |